Vimarsana
Biggest News Aggregation in the World

Par Pharmaceutical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Par Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Par Pharmaceutical Today - Breaking & Trending Today

DelveInsight Business Research, LLP: Postherpetic Neuralgia Market to Accelerate Significantly at a CAGR of 14% by 2034 - Vimarsana News

DelveInsight Business Research, LLP: Postherpetic Neuralgia Market to Accelerate Significantly at a CAGR of 14% by 2034

DelveInsight's analysis estimates that the postherpetic neuralgia market is expected to show positive growth, mainly attributed to increased incidence and the anticipated launch of novel therapies

Blood Pressure Medicine Sold In Louisiana Being Recalled - Vimarsana News

Blood Pressure Medicine Sold In Louisiana Being Recalled

Louisiana Residents need to check their Medication

Blood Pressure Medicine Sold In Louisiana Being Recalled - Vimarsana News

Blood Pressure Medicine Sold In Louisiana Being Recalled

Louisiana Residents need to check their Medication

Urgent: Recall Issued For Treprostinil Injection Due To Silicone Contamination - Vimarsana News

Urgent: Recall Issued For Treprostinil Injection Due To Silicone Contamination

Par Pharmaceutical's Canva Endo International initiates recall for Treprostinil Injection lot over silicone particulates issue. Learn why silicone in injectables can pose health risks and what actions to take for safety. Check if your Treprostinil 20mg/20mL Injection belongs to the affected Lot 57014. Stay informed for your well-being.

Par Widens Recall to Include 7 Lots of Treprostinil Injection - Vimarsana News

Par Widens Recall to Include 7 Lots of Treprostinil Injection

At this time, there have been no reports of adverse events associated with this recall.

Source: empr.com